Insider · CIK 0001303811

Kassberg Thomas Richard

Reports to the SEC for 3 companies · PHILADELPHIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001303811

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-19	PASGPassage BIO, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+10.5K sh	—	—	10,539
2025-05-28	PASGPassage BIO, Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+144K sh	—	—	143,789
2025-03-03	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−6,028 sh	$42.10	−$254K	265,238
2025-03-03	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	CBO & EVP	FTax Payment	−508 sh	$42.92	−$21.8K	264,730
2025-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+18.4K sh	—	—	271,266
2024-09-30	PASGPassage BIO, Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+174K sh	—	—	174,139
2024-03-11	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−11.5K sh	$49.93	−$575K	252,823
2024-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+17.8K sh	—	—	264,660
2024-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+957 sh	—	—	265,617
2024-03-01	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	CBO & EVP	FTax Payment	−274 sh	$53.69	−$14.7K	265,343
2024-03-01	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−1,011 sh	$53.76	−$54.4K	264,332
2024-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	CBO & EVP	AAward	+31.4K sh	—	—	31,400
2023-10-23	RAREUltragenyx Pharmaceutical Inc.M Exercise/Conversion	CBO & EVP	MExercise/Conversion	+39.9K sh	$6.86	+$274K	286,738
2023-10-23	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−39.9K sh	$32.78	−$1.31M	246,860
2023-10-23	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CBO & EVP	MExercise/Conversion	−39.9K sh	—	—	0
2023-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+2,663 sh	—	—	230,222
2023-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+22K sh	—	—	252,222
2023-03-01	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−1,968 sh	$45.27	−$89.1K	250,254
2023-03-01	RAREUltragenyx Pharmaceutical Inc.D Disposition to Issuer	CBO & EVP	DDisposition to Issuer	−3,394 sh	$45.65	−$155K	246,860
2023-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	CBO & EVP	AAward	+39.4K sh	—	—	39,400
2022-03-11	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−10.3K sh	$67.01	−$689K	227,559
2022-03-01	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−2,374 sh	$66.62	−$158K	213,840
2022-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+14K sh	—	—	227,840
2022-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	CBO & EVP	AAward	+24.9K sh	—	—	24,900
2021-12-10	RAREUltragenyx Pharmaceutical Inc.G Gift	CBO & EVP	GGift	−52 sh	—	—	216,214
2021-10-14	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−286 sh	$81.14	−$23.2K	216,266
2021-09-30	RAREUltragenyx Pharmaceutical Inc.M Exercise/Conversion	CBO & EVP	MExercise/Conversion	+110K sh	$0.31	+$34K	216,552
2021-09-30	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CBO & EVP	MExercise/Conversion	−110K sh	—	—	0
2021-05-06	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−363 sh	$113.69	−$41.3K	106,818
2021-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+5,500 sh	—	—	106,978
2021-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+4,636 sh	—	—	111,614
2021-03-01	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−4,572 sh	$138.17	−$632K	107,181
2021-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	CBO & EVP	AAward	+11K sh	—	—	11,000
2020-10-14	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−262 sh	$87.98	−$23.1K	101,478
2020-06-01	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	CBO & EVP	FTax Payment	−348 sh	$69.38	−$24.1K	101,740
2020-05-06	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	CBO & EVP	FTax Payment	−248 sh	$66.26	−$16.4K	101,675
2020-04-19	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	CBO & EVP	FTax Payment	−248 sh	$58.57	−$14.5K	101,923
2020-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+6,800 sh	—	—	98,475
2020-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+5,634 sh	—	—	104,109
2020-03-01	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	CBO & EVP	FTax Payment	−2,067 sh	$56.08	−$116K	102,171
2020-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	CBO & EVP	AAward	+20K sh	—	—	20,000
2019-10-14	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+1,434 sh	—	—	91,675
2019-06-01	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	CBO & EVP	FTax Payment	−346 sh	$54.93	−$19K	90,241
2019-05-21	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	CBO & EVP	FTax Payment	−381 sh	$59.50	−$22.7K	90,587
2019-05-06	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+1,434 sh	—	—	90,968
2019-04-19	RAREUltragenyx Pharmaceutical Inc.F Tax Payment	CBO & EVP	FTax Payment	−248 sh	$64.43	−$16K	89,226
2019-03-05	RAREUltragenyx Pharmaceutical Inc.S Sale	CBO & EVP	SSale	−832 sh	$65.52	−$54.5K	89,474
2019-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+7,000 sh	—	—	90,306
2019-03-01	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	CBO & EVP	AAward	+21.5K sh	—	—	21,500
2019-03-01	RAREUltragenyx Pharmaceutical Inc.A Award	CBO & EVP	AAward	+7,000 sh	—	—	90,305

Recent filings

Accepted (ET)
May 214
Kassberg Thomas Richard0001303811-26-000002
SEC(opens sec.gov)
May 304
Kassberg Thomas Richard0001415889-25-015054
SEC(opens sec.gov)
Mar 44
Kassberg Thomas Richard0000950170-25-032802
SEC(opens sec.gov)
Oct 24
Kassberg Thomas Richard0001415889-24-024416
SEC(opens sec.gov)
Mar 124
Kassberg Thomas Richard0000950170-24-029780
SEC(opens sec.gov)
Mar 54
Kassberg Thomas Richard0000950170-24-026661
SEC(opens sec.gov)
Oct 244
Kassberg Thomas Richard0001209191-23-053487
SEC(opens sec.gov)
Mar 34
Kassberg Thomas Richard0001209191-23-016046
SEC(opens sec.gov)

Companies

Address

ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR

PHILADELPHIA, PA, 19103